Novavax – Serum Institute of India, COVID-19 Vaccine Supply and License Agreement

• Post author:GHIAA Admin
• Post published:September 10, 2021
• Post category:

Continue ReadingNovavax – Serum Institute of India, COVID-19 Vaccine Supply and License Agreement

CEPI – Valneva, Chikungunya Vaccine Funding Agreement

• Post author:GHIAA Admin
• Post published:August 23, 2021
• Post category:

Continue ReadingCEPI – Valneva, Chikungunya Vaccine Funding Agreement

Fiocruz – AstraZeneca, COVID-19 Technological Order Agreement

• Post author:GHIAA Editor
• Post published:July 1, 2021
• Post category:

Continue ReadingFiocruz – AstraZeneca, COVID-19 Technological Order Agreement

NIH – GeoVax, Non-Exclusive Patent and Biological Materials License Agreement

• Post author:GHIAA Admin
• Post published:June 30, 2021
• Post category:

Continue ReadingNIH – GeoVax, Non-Exclusive Patent and Biological Materials License Agreement

BMGF – CureVac, Global Access Commitments Agreement

• Post author:GHIAA Editor
• Post published:June 30, 2021
• Post category:

Continue ReadingBMGF – CureVac, Global Access Commitments Agreement

CEPI – CureVac, Framework Partnering Agreement

• Post author:GHIAA Editor
• Post published:June 30, 2021
• Post category:

Continue ReadingCEPI – CureVac, Framework Partnering Agreement

Funder Development Partnering Agreement

• Post author:GHIAA Editor
• Post published:May 22, 2020
• Post category:

Continue ReadingFunder Development Partnering Agreement

PATH – Aridis, Rotavirus Vaccine Development Agreement

• Post author:GHIAA Editor
• Post published:May 22, 2020
• Post category:

Continue ReadingPATH – Aridis, Rotavirus Vaccine Development Agreement

MPP – BMS – Aurobindo, Daclatasvir Sublicense & Tech Transfer Agreement

• Post author:GHIAA Editor
• Post published:May 21, 2020
• Post category:

Continue ReadingMPP – BMS – Aurobindo, Daclatasvir Sublicense & Tech Transfer Agreement